News Labour's tax rises could damage economy, says UK pharma Corporation tax increase could damage UK's competitiveness, says ABPI
Views & Analysis Partnerships can drive more early-stage assets into clinical... Investors who see early-stage compounds and indications as valuable assets can support them to market.
Views & Analysis Novartis: UK market access starting to resemble austerity-hi... The new head of Novartis UK thinks the country has gone backwards in terms of access to medicines.
Views & Analysis Pharmacovigilance as a business enabler Industry may be limiting its options if safety takes a back seat to efficacy in trial design and product development.
Views & Analysis Healthcare evidence development: guilty until proven innocen... Pharma must prepare its case meticulously to support its new drug applications.
R&D Treating the chronic diseases GLP-1s miss, with Laurent Auda... Prive Bio CEO Laurent Audaly spoke with pharmaphorum during the JP Morgan Healthcare conference, discussing GLP-1s in the cardiometabolic space.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
